The store will not work correctly when cookies are disabled.
4-(3-(3-chlorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)-2-fluorobenzenesulfonamide
ID: ALA3985744
PubChem CID: 18385685
Max Phase: Preclinical
Molecular Formula: C18H15ClFNO4S
Molecular Weight: 395.84
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC1(C)OC(c2ccc(S(N)(=O)=O)c(F)c2)=C(c2cccc(Cl)c2)C1=O
Standard InChI: InChI=1S/C18H15ClFNO4S/c1-18(2)17(22)15(10-4-3-5-12(19)8-10)16(25-18)11-6-7-14(13(20)9-11)26(21,23)24/h3-9H,1-2H3,(H2,21,23,24)
Standard InChI Key: GNYXNVTTYSKYQM-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
30.9955 -6.2321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5910 -5.5264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1820 -6.2295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2808 -0.8225 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.2426 -1.6426 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
28.9719 -1.2657 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.9304 -5.0508 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.2538 -5.0445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9963 -4.2663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1800 -4.2739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0317 -5.2949 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.6968 -3.6168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0262 -2.8677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5424 -2.2100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7293 -2.3002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4024 -3.0538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8881 -3.7083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4687 -3.6044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2830 -3.6853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7583 -3.0215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4205 -2.2764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6027 -2.1992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1310 -2.8640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4319 -1.7344 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8705 -1.4616 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
33.5716 -3.1013 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
5 4 2 0
6 5 2 0
7 2 1 0
2 8 1 0
8 9 1 0
9 10 2 0
10 7 1 0
8 11 2 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
10 12 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
9 18 1 0
15 5 1 0
5 24 1 0
14 25 1 0
20 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 395.84 | Molecular Weight (Monoisotopic): 395.0394 | AlogP: 3.37 | #Rotatable Bonds: 3 |
Polar Surface Area: 86.46 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.63 | CX Basic pKa: ┄ | CX LogP: 3.55 | CX LogD: 3.53 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.86 | Np Likeness Score: -0.60 |
References
1. (2002) 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors, |